What is AngioDynamics's impairment of assets held for sale?

AngioDynamics (ANGO) reported impairment of assets held for sale of $38K in Q4 2025.

How has AngioDynamics's impairment of assets held for sale changed year-over-year?

AngioDynamics's impairment of assets held for sale decreased by 0.0% year-over-year, from $38K to $38K.

AngioDynamics ANGO Impairment of assets held for sale

Impairment of assets held for sale at other companies

NordsonNDSN

——

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's impairment of assets held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's impairment of assets held for sale?: AngioDynamics (ANGO) reported impairment of assets held for sale of $38K in Q4 2025.
How has AngioDynamics's impairment of assets held for sale changed year-over-year?: AngioDynamics's impairment of assets held for sale decreased by 0.0% year-over-year, from $38K to $38K.